![](/img/cover-not-exists.png)
245 A phase III trial of EUR-1008 in young cystic fibrosis (CF) patients with exocrine pancreatic insufficiency (EPI)
J. Wooldridge, R. Amaro-Galvez, K. Blake, B. Chatfield, S. McColley, M.S. Woo, C. Straforini, M. AnelliVolume:
6
Year:
2007
Language:
english
DOI:
10.1016/s1569-1993(07)60228-8
File:
PDF, 57 KB
english, 2007